[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pulsed-electromagnetic-therapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pulsed-electromagnetic-therapy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100637189","efficacy-of-pulsed-electromagnetic-field-therapy-on-women-with-endometriosis-100637189",false,"NCT07592403","Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis","Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis, A Randomized Controlled Trial","Inclusion Criteria:\n\n1. Women aged 18 to 45 years\n2. Clinically, radiologically, or laparoscopically diagnosed endometriosis\n3. Chronic pelvic pain persisting for at least 6 months\n4. Stable pharmacological or hormonal treatment for at least 3 months before enrollment\n5. Ability to understand study procedures and provide written informed consent\n\nExclusion Criteria:\n\n1. Pregnancy or planned pregnancy during the study period\n2. History of gynecological or pelvic malignancy\n3. Active pelvic inflammatory disease or acute pelvic infection\n4. Implanted electronic medical devices such as pacemakers or neurostimulators\n5. Previous pelvic surgery within the past 6 months\n6. Participation in another clinical trial during the previous 3 months\n7. Neurological, rheumatological, or severe musculoskeletal disorders affecting assessment procedures\n8. Contraindications to electromagnetic therapy","FEMALE","18 Years","45 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.",[27,28,29],"Endometriosis","Pulsed Electromagnetic Therapy","Trans Perineal Ultrasound",[27,31,32],"Pulsed Electromagnetic Field Therapy","trans perineal ultrasound","RECRUITING","2026-05-15",{"date":36,"type":37},"2026-05-19","ACTUAL",{"date":39,"type":37},"2026-05-16",{"date":41,"type":21},"2027-01-30",{"name":43,"class":44},"Beni-Suef University","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":63,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":72,"leadSponsor":74,"locationsCount":45},"100639970","effects-of-extracorporeal-shockwave-therapy-versus-pulsed-electromagnetic-field-therapy-in-females-with-sexual-dysfunction-100639970","NCT07584174","Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction.","Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction: a Randomized Controlled Trial","Inclusion Criteria:\n\n1. Female participants aged 20-50 years diagnosed with female sexual dysfunction (FSFI score \\\u003C26.55), reporting symptoms of reduced sexual desire, arousal dysfunction, orgasmic dysfunction, or dyspareunia.\n2. Premenopausal women in a stable sexual relationship for at least 6 months and sexually active during the previous month.\n3. Symptoms persisting for at least 3 months before enrollment.\n4. Ability to understand study procedures and provide written informed consent.\n5. Willingness to refrain from initiating any additional treatment for sexual dysfunction during the study period\n\nExclusion Criteria:\n\n1. Pregnancy or planned pregnancy during the study period.\n2. Pelvic surgery within the previous 6 months.\n3. Active pelvic inflammatory disease, genital infection, or unexplained vaginal bleeding.\n4. Neurological disorders affecting pelvic floor or sexual function.\n5. Severe pelvic organ prolapse, severe urinary incontinence, or significant pelvic anatomical abnormalities.\n6. Current hormonal therapy or use of medications known to affect sexual function, including antidepressants or antipsychotics.\n7. Severe psychiatric disorders or cognitive impairment limiting participation.\n8. Menopause or perimenopausal status.\n9. Uncontrolled systemic diseases such as diabetes mellitus, hypertension, cardiovascular disease, or thyroid disorders.\n10. Presence of malignancy, pelvic radiation history, or severe chronic pelvic pain disorders.\n11. Contraindications to ESWT or PEMF including cardiac pacemakers or implanted electronic devices, coagulation disorders, anticoagulant therapy, epilepsy, or metal implants in the pelvic region.\n12. Current participation in another clinical trial or receipt of physiotherapy for sexual dysfunction within the previous 3 months.","20 Years","50 Years",{"count":56,"type":21},90,[24],"This is a prospective, three-arm, parallel-group, assessor-blinded randomized controlled trial designed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) combined with pelvic floor muscle training (PFMT), pulsed electromagnetic field stimulation (PEMF) combined with PFMT, and PFMT alone in Females with sexual dysfunction. Participants will be randomly allocated in a 1:1:1 ratio, and the study duration is 16 weeks, including an 8-week intervention period and an 8-week follow-up period.",[60,61,62,28],"Female Sexual Dysfunction (FSD)","Pelvic Floor Muscle Training","Shock Wave",[64,65,66,67],"extracorporeal shock wave therapy","pulsed electromagnetic filed therapy","pelvic floor muscles training","females sexual dysfunction","2026-05-14",{"date":70,"type":37},"2026-05-18",{"date":68,"type":37},{"date":73,"type":21},"2027-01-15",{"name":75,"class":44},"Benha University"]